Investor Relations
Corporate Information
Corporate Governance
and Responsibility
News and Events
Investor Conference
News Releases
In the News
Future Events
Past Events & Presentations
Stock Information &
Investor Tools
Financial Information
Tax Cost Basis
SEC Filings
Annual Reports
Quarterly Snapshot
Historical Financial Tables
Shareholder Services
2009 Proxy Statement
Stock Transfer Agent
Electronic Delivery Enrollment
Investor FAQs
Contact Information

2009 Investor Conference



Edwards Lifesciences is hosting its 2009 Investor Conference on December 9 and 10 at its corporate headquarters in Irvine, California.

The event will include discussions about the company's growth strategy, exciting interventional technologies including transcatheter heart valve replacement, and a detailed financial outlook for 2010. Join us and learn more about Edwards’ plans for continued growth!

2009 Investor Conference Invitation


CONFERENCE AGENDA

Wednesday, December 9, 2009 (not available via webcast)
5:00 p.m. – 6:45 p.m. Registration
Product Demonstrations
Manufacturing and R&D Tour
Wine Tasting and Hors d’oeuvres
6:45 p.m. – 8:00 p.m. The Glucose Monitoring Opportunity - Carlyn D. Solomon
Guest Speakers:
Steven V. Edelman, MD
Anthony P. Furnary, MD, FACS, FACC
Terrance H. Gregg, President & CEO of DexCom
Kelly Close, President of Close Concerns
8:00 p.m. Adjourn
Thursday, December 10, 2009 (available via webcast)
7:00 a.m. – 8:00 a.m. Registration
Continental Breakfast
8:00 a.m. – 10:00 a.m. Welcome and Opening Remarks - Michael A. Mussallem

Transcatheter Heart Valve Therapy - Larry L. Wood
Guest Speaker: John G. Webb, MD, FRCPC, FACC

Surgical Heart Valve Therapy - Donald E. Bobo, Jr.
Guest Speaker: Vinod H. Thourani, MD
10:00 a.m. - 10:15 a.m. Morning Break
10:15 a.m. - 11:30 a.m. Innovations in Critical Care - Carlyn D. Solomon
Guest Speaker: Joshua A. Bloomstone, MD

2010 Financial Outlook - Thomas M. Abate

Closing Remarks - Michael A. Mussallem
11:30 a.m. - 12:30 p.m. Webcast Concludes
Lunch with Management (optional)
12:30 p.m. Conference Adjourns


If you have any questions, please contact Laci Smith in the Investor Relations department at (949) 250-2816 or via email at Laci_Smith@edwards.com.

Contact Us | Legal Terms | Privacy Policy | © 2010 Edwards Lifesciences LLC. All rights reserved.